September 5, 2024

Attention CRAs: Travel funds are available for the Fall 2024 Group Meeting (apply now)

August 30, 2024

Registration is now open for the Fall 2024 Group Meeting

August 30, 2024

Attention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD Health Equity Travel Scholarship to attend the Fall 2024 Group Meeting

August 29, 2024

How the CompassHER2 pCR trial (EA1181) and other novel studies seek to optimize HER2+ breast cancer management

August 28, 2024

Attention radiation oncologists and trainees: Travel funds are available for the Fall 2024 Group Meeting (apply now)

August 21, 2024

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

August 21, 2024

The implications of the E3311 trial in HPV+ head and neck cancer: Dr. Ranee Mehra

August 20, 2024

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

August 17, 2024

Nivolumab’s role in esophageal cancer neoadjuvant therapy: Dr. Jennifer Eads (study EA2174)

ECOG-ACRIN Cancer Research Group